Dinner Innovation Theater (Non-Accredited): One Patient's Journey: A Rapid-Acting Antidepressant that Modulates Glutamate, Sigma-1, and Monoaminergic Pathways

Dinner will be served. Seating is limited to 100 and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs. Presenter(s): Michael Asbach, DMSc, PA-C & Rebecca Kraus Barbee, PA-C, CAQ-Psych This presentation is sponsored by Axsome Therapeutics, Inc.